Reply
Hannah S. J. Choi, Willem P. Brouwer, Bettina E. Hansen, Harry L. A. Janssen, Keyur Patel – 8 October 2019
Notices
8 October 2019
Cost‐Effectiveness of Noninvasive Screening for Alcohol‐Related Liver Fibrosis
Lars Asphaug, Maja Thiele, Aleksander Krag, Hans Olav Melberg – 8 October 2019
Biallelic Mutations in Tetratricopeptide Repeat Domain 26 (Intraflagellar Transport 56) Cause Severe Biliary Ciliopathy in Humans
Ranad Shaheen, Saud Alsahli, Nour Ewida, Fatema Alzahrani, Hanan E. Shamseldin, Nisha Patel, Awad Al Qahtani, Homoud Alhebbi, Amal Alhashem, Tarfa Al‐Sheddi, Rana Alomar, Eman Alobeid, Mohamed Abouelhoda, Dorota Monies, Abdulrahman Al‐Hussaini, Muneerah A. Alzouman, Mohammad Shagrani, Eissa Faqeih, Fowzan S. Alkuraya – 8 October 2019
Instructions to Authors
8 October 2019
Fat Accumulation, Liver Fibrosis, and Metabolic Abnormalities in Chinese Patients With Moderate/Severe Versus Mild Hepatic Steatosis
Wei Zhang, Rui Huang, Yi Wang, Huiying Rao, Lai Wei, Grace L. Su, Anna S. Lok – 7 October 2019 – Several drugs in development for nonalcoholic fatty liver disease (NAFLD) aim to decrease the amount of fat in the liver. We compared quantity and quality of fat in subcutaneous, visceral and muscle compartments, liver fibrosis, and prevalence of metabolic abnormalities between Chinese patients with moderate/severe hepatic steatosis versus those with mild hepatic steatosis. NAFLD patients were prospectively recruited from Peking University People's Hospital in Beijing, China.
Longterm Outcomes of Living Donor Liver Transplantation for Glycogen Storage Disease Type 1b
Seiichi Shimizu, Seisuke Sakamoto, Reiko Horikawa, Akinari Fukuda, Hajime Uchida, Masahiro Takeda, Yusuke Yanagi, Rie Irie, Takako Yoshioka, Mureo Kasahara – 6 October 2019 – Glycogen storage disease (GSD) type 1b (Online Mendelian Inheritance in Man [OMIM] 232220) is an autosomal recessive inborn error of carbohydrate metabolism caused by defects in glucose‐6‐phosphate translocase. GSD1b patients have severe hypoglycemia with several clinical manifestations of hepatomegaly, obesity, a doll‐like face, and neutropenia.
Letter to the Editor: Impact of Nonalcoholic Steatohepatitis on Liver‐Related Outcomes in Chronic Hepatitis B
Rui Huang, Jian Wang, Zhaoping Zhang, Xiaomin Yan, Chao Wu – 6 October 2019
Loss of Xanthine Oxidoreductase Potentiates Propagation of Hepatocellular Carcinoma Stem Cells
Qikai Sun, Zechuan Zhang, Yijun Lu, Qiaoyu Liu, Xiaoliang Xu, Jianbo Xu, Yang Liu, Hailong Yu, Decai Yu, Beicheng Sun – 3 October 2019
LiverLearning®: 2019 Webinar: Liquid Biopsy in Hepatocellular Carcinoma: Applications in Surveillance and Prediction of Treatment Response
Liquid biopsy entails the analysis of tumor components released by cancer cells to biological fluids such as blood, saliva or cerebrospinal fluid. It has emerged as a promising source of novel biomarkers in the clinical management of patients with hepatocellular carcinoma. We will discuss the current developmental status of this technology and how it may change decision-making in patients with hepatocellular carcinoma. We will utilize a live webinar format that will be recorded for on-demand viewing on Liver Learning ® .Lewis R. Roberts Dr. Lewis R.